Watch Naiyer A. Rizvi, MD, Ezra Cohen, MD, FRCPSC, FASCO, and Susan F. Slovin, MD, PhD Discuss the Value of CME
Value of Oncology CME
Dr. Slovin explains that CME is important in providing a venue for oncologists to learn about new drugs so that they are prepared to integrate them into practice once they come on the market. Another key takeaway from CME is that learners are able to identify experts who may be helpful to them, to provide guidance and address challenges in their practice. Dr. Cohen adds that it’s important to have a platform like CME where rapid advancements in cancer can be easily translated for the practicing oncologist. Without CME, it’s impossible to stay abreast of practice-changing advancements that will ultimately affect the care of patients.